Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-26-000008

Business Development Director sold 917 shares at $0.80 ($734)

From the SEC's structured data for this filing

Trades in this filing

Christianson Mark · Business Development Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-12 Sale : show line 1 in the form −817 $0.80 $654 214,383 D
2026-03-13 Sale : show line 2 in the form −100 $0.80 $80 214,283 D
Open-market sales · 917 sh · avg $0.80 · $734
Loading xslF345X05/primary_doc.xml…